Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT)

被引:66
作者
Seaton, R. A. [1 ]
Nathwani, D.
Burton, P.
McLaughlin, C.
MacKenzie, A. R.
Dundas, S.
Ziglam, H.
Gourlay, Y.
Beard, K.
Douglas, E.
机构
[1] Gartnavel Royal Hosp, Infect Unit, Brownlee Ctr, Glasgow, Lanark, Scotland
[2] Ninewells Hosp, Infect Unit, Dundee DD1 9SY, Scotland
[3] Stobhill Hosp, Clin Audit Dept, Glasgow, Lanark, Scotland
[4] Victoria Infirm, Dept Pharm, Glasgow G42 9TY, Lanark, Scotland
[5] Aberdeen Royal Infirm, Infect Unit, Aberdeen, Scotland
[6] Monklands Gen Hosp, Infect Unit, Airdrie, Scotland
[7] Gartnavel Royal Hosp, Dept Pharm, Glasgow, Lanark, Scotland
[8] Victoria Infirm, Glasgow G42 9TY, Lanark, Scotland
[9] NHS Greater Glasgow, Glasgow Area Med Evaluat Unit, Glasgow, Lanark, Scotland
关键词
point prevalence study; antimicrobial therapy; antibiotic therapy;
D O I
10.1016/j.ijantimicag.2006.10.020
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A point prevalence survey of antimicrobial prescribing was performed in 10 Scottish hospitals using the Glasgow Antimicrobial Audit Tool (GAAT). Appropriateness of the intravenous (IV) route was determined by an infectious diseases physician (IDP) and by a computerised algorithm. The IDP also estimated IV agent appropriateness. Each hospital was surveyed on a single day. Of 3826 patients surveyed, 1079 (28.3%) received an antibiotic, 381 (35.3%) intravenously; 197 (28.2%) orally treated had prior IV therapy. Median duration of IV was 4 days (IQR 2-7 days) and oral switch was 3.5 days (2-6). IV route was appropriate in 84% (IDP) and 84.8% (algorithm). Choice of agent was appropriate in 80% (IDP). Third-generation cephalosporins (3GC) (28.3%) were most frequent, followed by co-amoxiclav (20.2%), metroniclazole (19.2%) and glycopeptides (18.6%). Regional differences were seen. The study shows it is possible to coordinate, collect and compare data from UK hospitals using the GAAT. Data may usefully inform local and national audit and support prescribing initiatives. (c) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:693 / 699
页数:7
相关论文
共 20 条
[1]   Use of a treatment protocol in the management of community-acquired lower respiratory tract infection [J].
Al-Eidan, FA ;
McElnay, JC ;
Scott, MG ;
Kearney, MP ;
Corrigan, J ;
McConnell, JB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) :387-394
[2]  
[Anonymous], J INFECT
[3]  
[Anonymous], 2002, INT J PHARM PR, DOI DOI 10.1111/J.2042-7174.2002.TB00597.X
[4]   Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis [J].
Ansari, F ;
Gray, K ;
Nathwani, D ;
Phillips, G ;
Ogston, S ;
Ramsay, C ;
Davey, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :842-848
[5]   Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia [J].
Byl, B ;
Clevenbergh, P ;
Jacobs, F ;
Struelens, MJ ;
Zech, F ;
Kentos, A ;
Thys, JP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :60-66
[6]   ORAL VERSUS INTRAVENOUS ANTIBIOTICS FOR COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTION IN A GENERAL-HOSPITAL - OPEN, RANDOMIZED CONTROLLED TRIAL [J].
CHAN, R ;
HEMERYCK, L ;
OREGAN, M ;
CLANCY, L ;
FEELY, J .
BRITISH MEDICAL JOURNAL, 1995, 310 (6991) :1360-1362
[7]   The problem with cephalosporins [J].
Dancer, SJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (04) :463-478
[8]   Antibiotic optimization - An evaluation of patient safety and economic outcomes [J].
Fraser, GL ;
Stogsdill, P ;
Dickens, JD ;
Wennberg, DE ;
Smith, RP ;
Prato, BS .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (15) :1689-1694
[9]   Do smoking parents seek the best advice for their asthmatic children? [J].
Friend, JAR .
THORAX, 2001, 56 (01) :1-1
[10]   The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital [J].
Gomez, J ;
Cavero, SJC ;
Cardona, JLH ;
Nunez, ML ;
Gomez, JR ;
Canteras, M ;
Valdes, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :309-314